Clinical Trial Update: Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether combining enalapril and losartan affects proteinuria and inflammatory biomarkers in macroalbuminuric diabetic nephropa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Enalapril (enalapril)
• Losartan (losartan)

Snippet

Sponsor: University of Sao Paulo | Conditions: Macroalbuminuric Diabetic Nephropathy | Phase 4 | Status: COMPLETED